PRGO Q2 2021 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$981M+3.4% YoY

Gross Profit

$349M35.6% margin

Operating Income

-$126M-12.8% margin

Net Income

-$58M-5.9% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-2.9%

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$176M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11.2B

Total Liabilities

$5.7B

Stockholders' Equity

$5.5B

Cash & Equivalents

$318M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$981M	$949M	+3.4%
Gross Profit	$349M	$347M	+0.5%
Operating Income	-$126M	$63M	-300.8%
Net Income	-$58M	$61M	-195.2%

Revenue Segments

Consumer Self-Care Americas

$622M63%

Consumer Self-Care International

$359M37%

Geographic Segments

UNITED STATES

$590M60%

Europe

$348M35%

Other Geographical Areas

$43M4%

IRELAND

$5M1%